// App-Quantinova.ai

e20019 : Outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with cisplatin and irinotecan with concurrent thoracic radiotherapy (CRT): A multi-disciplinary thoracic oncology experience at East Carolina University.

Researchers

Presenter

  • Jessica R. Hildebrand

Principal Investigators

  • Sulochana Devi Cherukuri

  • Hyder Husain Arastu

  • Clinton Leinweber

  • Chipman Robert Geoffrey Stroud

  • Teresa Parent

  • Cynthia R. Cherry

  • Jessica Hardin

  • Paul R. Walker

Medical Centers

  • East Carolina Univ, Winterville, NC

  • Vidant Medical Center, Greenville, NC

  • Leo Jenkins Cancer Center Brody School of Medicine at East Carolina University, Greenville, NC

  • Leo Jenkins Cancer Ctr, Greenville, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Brain metastasis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • cisplatin + irinotecan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved